ArticleClinical rheumatology2012

Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales: addressing treatment outside the current NICE guidance.

Yee Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.